ArticleBMC cancer2026

Serglycin-ROS axis mediates synergistic lethality of PI3Kγ inhibition and Azacitidine in TP53-mutated AML.

Guiqin Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.